Basic info
Industry
biotechnology research
Sectors
Biotechnology
rhinovirus
dengue
herpes
human immunodeficiency virus
neutralization
CMV
Influenza
Diagnostics
AAV
RSV
influenza
HCV
CRO
neutralization assay
Innovation Management
retrovirus
DENV
Pseudovirus
LASV
Health Care
plaque reduction assay
Antivirals
antiviral
plaque assay
anti-viral
virology
vaccine
Life Science
Vaccines
infectious diseases
Ebola
HCMV
flu
antiviral assays
LCMV
poliovirus
HIV
antiviral services
parainfluenza
Zika
PRA
ZIKV
cytomegalovirus
adenovirus
Health Diagnostics
HRV
EBOV
respiratory syncytial virus
drug discovery
virus
HBV
coronavirus
Lassa
hepatitis
HSV-1
HSV-2
antibodies
chikungunya
Date founded
2008
Funding rounds raised
Total raised
$3M
from 1 investors over 1 rounds
R
RetroVirox Inc. raised $3M on March 12, 2015
Investors: National Institutes of Health